Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1978 Nov;62(5):1014–1019. doi: 10.1172/JCI109205

Reversal by methysergide of inhibition of insulin secretion by prostaglandin E in the dog.

R P Robertson, R J Guest
PMCID: PMC371860  PMID: 361755

Abstract

These studies were designed to examine whether interrelationships exist between serotonin and prostaglandin E (PGE) during regulation of insulin secretion in dogs in vivo. In our studies serotonin was found to inhibit insulin responses to intravenous glucose. This inhibition was not reversed by complete adrenergic blockade provided through combined phentolamine and propranolol pretreatment. This property of serotonin is similar to that of PGE which also inhibits glucose-induced insulin secretion in vivo independently of adrenergic activity. To investigate whether these effects of serotonin and PGE are related, studies with methysergide (a serotonin antagonist) and indomethacin (a PGE synthesis inhibitor) were performed. Methysergide reversed the effects of both PGE and serotonin. In contrast, indomethacin did not diminish the inhibitory effect of serotonin upon insulin secretion. It is hypothesized that endogenous serotonin may play a role in the inhibitory effect of PGE upon insulin secretion in dogs in vivo.

Full text

PDF
1019

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cegrell L. The occurrence of biogenic monoamines in the mammalian endocrine pancreas. Acta Physiol Scand Suppl. 1968;314:1–60. [PubMed] [Google Scholar]
  2. Federspil G., Casara D., Pedrazzoli S., Sicolo N., Scandellari C. In vivo studies on 5-hydroxytryptamine and insulin secretion in dogs and in man. Diabetologia. 1974 Feb;10(1):13–17. doi: 10.1007/BF00421408. [DOI] [PubMed] [Google Scholar]
  3. Flower R. J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev. 1974 Mar;26(1):33–67. [PubMed] [Google Scholar]
  4. Hamamdzić M., Malik K. U. Prostaglandins in adrenergic transmission of isolated perfused rat pancreas. Am J Physiol. 1977 Feb;232(2):E201–E209. doi: 10.1152/ajpendo.1977.232.2.E201. [DOI] [PubMed] [Google Scholar]
  5. Lechín F., Coll-García E., Van Der Dijs B., Peña F., Bentolila A., Rivas C. The effect of serotonin (5-HT) on insulin secretion. Acta Physiol Lat Am. 1975;25(4):339–346. [PubMed] [Google Scholar]
  6. Lundquist I., Ekholm R., Ericson L. E. Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors. Diabetologia. 1971 Dec;7(6):414–422. doi: 10.1007/BF01212056. [DOI] [PubMed] [Google Scholar]
  7. Lundquist I., Sundler F., Hâkanson R., Larsson L. I., Heding L. G. Differential changes in the 5-hydroxytryptamine and insulin content of guinea-pig B-cells. Endocrinology. 1975 Oct;97(4):937–947. doi: 10.1210/endo-97-4-937. [DOI] [PubMed] [Google Scholar]
  8. Porte D., Jr A receptor mechanism for the inhibition of insulin release by epinephrine in man. J Clin Invest. 1967 Jan;46(1):86–94. doi: 10.1172/JCI105514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Porte D., Jr, Pupo A. A. Insulin responses to glucose: evidence for a two pool system in man. J Clin Invest. 1969 Dec;48(12):2309–2319. doi: 10.1172/JCI106197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Quickel K. E., Jr, Feldman J. M., Lebovitz H. E. Enhancement of insulin secretion in adult onset diabetics by methysergide maleate: evidence for an endogenous biogenic monoamine mechanism as a factor in the impaired insulin secretion in diabetes mellitus. J Clin Endocrinol Metab. 1971 Dec;33(6):877–881. doi: 10.1210/jcem-33-6-877. [DOI] [PubMed] [Google Scholar]
  11. Quickel K. E., Jr, Feldman J. M., Lebovitz H. E. Inhibition of insulin secretion by serotonin and dopamine: species variation. Endocrinology. 1971 Nov;89(5):1295–1302. doi: 10.1210/endo-89-5-1295. [DOI] [PubMed] [Google Scholar]
  12. Rickert D. E., Fischer L. J. Cyproheptadine and beta cell function in the rat: insulin secretion from pancreas segments in vitro. Proc Soc Exp Biol Med. 1975 Oct;150(1):1–6. doi: 10.3181/00379727-150-38961. [DOI] [PubMed] [Google Scholar]
  13. Robertson R. P., Chen M. A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus. J Clin Invest. 1977 Sep;60(3):747–753. doi: 10.1172/JCI108827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Robertson R. P., Gavareski D. J., Porte D., Jr, Bierman E. L. Inhibition of in vivo insulin secretion by prostaglandin E1. J Clin Invest. 1974 Aug;54(2):310–315. doi: 10.1172/JCI107766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Robertson R. In vivo insulin secretion: prostaglandin and adrenergic interrelationships. Prostaglandins. 1974 Jun 25;6(6):501–508. doi: 10.1016/s0090-6980(74)80060-2. [DOI] [PubMed] [Google Scholar]
  16. Saccà L., Perez G. Influence of prostaglandins on plasma glucagon levels in the rat. Metabolism. 1976 Feb;25(2):127–130. doi: 10.1016/0026-0495(76)90041-x. [DOI] [PubMed] [Google Scholar]
  17. Saccà L., Perez G., Rengo F., Pascucci I., Condorelli M. Reduction of circulating insulin levels during the infusion of different prostaglandins in the rat. Acta Endocrinol (Copenh) 1975 Jun;79(2):266–274. doi: 10.1530/acta.0.0790266. [DOI] [PubMed] [Google Scholar]
  18. Smith P. H., Woods S. C., Porte D., Jr Phentolamine blocks the somatostatin-mediated inhibition of insulin secretion. Endocrinology. 1976 Apr;98(4):1073–1076. doi: 10.1210/endo-98-4-1073. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES